Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biotime Inc (BTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 334,937
  • Shares Outstanding, K 126,870
  • Annual Sales, $ 5,920 K
  • Annual Income, $ 33,570 K
  • 36-Month Beta 2.00
  • Price/Sales 94.35
  • Price/Cash Flow N/A
  • Price/Book 1.52

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.10 +30.00%
on 12/29/17
2.80 -2.50%
on 01/08/18
+0.43 (+18.70%)
since 12/22/17
3-Month
2.10 +30.00%
on 12/29/17
2.80 -2.50%
on 01/08/18
+0.14 (+5.41%)
since 10/23/17
52-Week
2.10 +30.00%
on 12/29/17
3.62 -24.59%
on 03/17/17
-0.54 (-16.51%)
since 01/23/17

Most Recent Stories

More News
Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, American Superconductor and Stratasys

Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, American Superconductor and Stratasys

AMSC : 5.07 (-0.59%)
RTTR : 0.34 (+2.11%)
BTX : 2.73 (+3.41%)
SSYS : 22.68 (-0.04%)
ONVO : 1.40 (+1.45%)
Try Rising P/E Investing With 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

AMSC : 5.07 (-0.59%)
RTTR : 0.34 (+2.11%)
BTX : 2.73 (+3.41%)
SSYS : 22.68 (-0.04%)
ONVO : 1.40 (+1.45%)
Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, Signal Genetics and Stratasys

Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, Signal Genetics and Stratasys

RTTR : 0.34 (+2.11%)
BTX : 2.73 (+3.41%)
MGEN : 8.11 (-0.25%)
SSYS : 22.68 (-0.04%)
ONVO : 1.40 (+1.45%)
Keep Faith in Rising P/E: Play 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

RTTR : 0.34 (+2.11%)
BTX : 2.73 (+3.41%)
MGEN : 8.11 (-0.25%)
SSYS : 22.68 (-0.04%)
ONVO : 1.40 (+1.45%)
Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime

Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime

AKTX : 3.46 (-0.86%)
BTX : 2.73 (+3.41%)
JYNT : 5.10 (-0.20%)
ARDX : 7.90 (+3.95%)
TLRD : 24.46 (-1.25%)
5 Affordable Breakout Stocks Offering Excellent Returns

If properly implemented, such a strategy has the ability to deliver impressive returns.

AKTX : 3.46 (-0.86%)
BTX : 2.73 (+3.41%)
JYNT : 5.10 (-0.20%)
ARDX : 7.90 (+3.95%)
TLRD : 24.46 (-1.25%)
BioTime - A Multi-Faceted Regenerative Medicine Company

BEND, OR / ACCESSWIRE / September 22, 2017 / BioTime, Inc. (NASDAQ: BTX), Sylva International has always been extremely interested in regenerative medicines because they've shown tremendous promise in...

CDXC : 5.27 (-6.73%)
BTX : 2.73 (+3.41%)
AgeX Therapeutics CEO Michael D. West to Participate in Fireside Chat with J. Craig Venter at the Cell & Gene Therapy CEO Forum

AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE American: BTX), announces that Chief Executive Officer Michael D. West, Ph.D., who also serves as Co-CEO of BioTime,...

BTX : 2.73 (+3.41%)
BioTime Co-CEO Adi Mohanty to Participate in Panel Discussion at the Cell & Gene Therapy CEO Forum

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Co-Chief...

BTX : 2.73 (+3.41%)
BioTime to Present at the Ladenburg Thalmann 2017 Healthcare Conference

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that Adi Mohanty,...

BTX : 2.73 (+3.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More

Business Summary

BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine. The foundation of its core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body....

See More

Key Turning Points

2nd Resistance Point 2.86
1st Resistance Point 2.80
Last Price 2.73
1st Support Level 2.64
2nd Support Level 2.54

See More

52-Week High 3.62
Fibonacci 61.8% 3.04
Fibonacci 50% 2.86
Last Price 2.73
Fibonacci 38.2% 2.68
52-Week Low 2.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.